Gelatinase B functions as regulator and effector in leukocyte biology

Journal of Leukocyte Biology

Volumn 69, Issue 6, 2001, Pages 851-859

  Opdenakker, G ^a   Van den Steen, P E ^a   Dubois, B ^a   Nelissen, I ^a   Van Coillie, E ^a   Masure, S ^a   Proost, P ^a   Van Damme, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Extracellular matrix; Matrix metalloproteinases; Neutrophils; TIMP

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA CHEMOKINE; BETA THROMBOGLOBULIN; CHEMOTACTIC FACTOR; GELATINASE A; GELATINASE B; GRO ALPHA; GROWTH RELATED OPEN READING FRAME ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 2; RANTES; THROMBOCYTE FACTOR 4; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; BONE REMODELING; CATALYSIS; CONFERENCE PAPER; DEGRANULATION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; LEUKOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; SUBFERTILITY;

AUTOIMMUNE DISEASES; CHEMOKINES; CHROMOSOMES, HUMAN, PAIR 20; CYTOKINES; ENZYME ACTIVATION; ENZYME INDUCTION; EXTRACELLULAR MATRIX; HUMANS; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; MACROMOLECULAR SUBSTANCES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASMS; NEUTROPHILS; ORGAN SPECIFICITY; PHENOTYPE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0034979103     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. Cytokine-regulated proteases in autoimmune diseases
2. The molecular basis of leukocytosis
3. Matrix metalloproteinases
4. Gelatinase B
5. Protein translocation across the endoplasmic reticulum
6. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
7. Formation of a covalent Hg-Cys bond during mercurial activation of PMNC procollagenase gives evidence of a cysteine-switch mechanism
8. Structural characterization of the catalytic active site in the latent and active natural gelatinase B from human neutrophils
9. SV-40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages
10. The glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin
11. Presence of a gelatin-specific proteinase and its latent form in human leucocytes
12. Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages
13. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
14. Natural human monocyte gelatinase B and its inhibitor
15. The cytokine-protease connection: Identification of a 96 kDa THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers
16. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis
17. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4 and GRO-α and leaves RANTES and MCP-2 intact
18. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
19. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity
20. The individual regulation of granule protein mRNA during neutrophil maturation explains the heterogeneity of neutrophil granules
21. Prevention of interleukin-8-induced mobilization of haematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against gelatinase B (MMP-9)
22. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B)
23. Production of gelatinase B by human T-cells
24. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: Implications of ICAM-1
25. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
26. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
27. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalitis and cleaves myelin basic protein
28. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
29. Matrix metalloproteinases and diseases of the CNS
30. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
31. Altering the genome by homologous recombination
32. Mouse gelatinase B: cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation
33. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
34. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
35. Gelatinase B deficiency impairs reproduction
36. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid
37. Experimental metastasis is suppressed in MMP-9-deficient mice
38. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
39. Gelatinase B is required for alveolar bronchiolization after intra-tracheal bleomycin
40. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse
41. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response
42. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo
43. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
44. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
45. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
46. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B
47. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells
48. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene
49. Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease
50. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis
51. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis
52. 3.8-10 is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells
53. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
54. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis
55. Gelatinase B: Structure, regulation, and function
56. Type IV eollagenases in tumor invasion and metastasis
57. Regulation of gelatinase B/MMP-9 in leukocytes by plant lectins
58. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression
59. Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils
60. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
61. Activation of progelatinase B (MMP-9) by gelatinase A
62. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator
63. Glycoforms modify the dynamic stability and functional activity of an enzyme
64. Generation of biologically active IL-1β by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1β processing
65. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
66. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2, MCP-3) belonging to the chemokine family
67. The MCP/eotaxin subfamily of CC chemokines
68. Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist
69. 2-terminal residues
70. Chemotactic factors, passive invasion and metastasis of cancer cells
71. Novel monocyte chemoattractants in cancer
72. Interleukin 8 expression regulates tumorigenicity and metastasis in androgen-independent prostate cancer